137 related articles for article (PubMed ID: 8891704)
1. Hope and the limits of research.
Daugherty CK; Geller G
Hastings Cent Rep; 1996; 26(5):20; discussion 20-2. PubMed ID: 8891704
[No Abstract] [Full Text] [Related]
2. An IRB member's perspective on access to innovative therapy.
Moore DL
Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
[No Abstract] [Full Text] [Related]
3. What's the price of a research subject? Approaches to payment for research participation.
Dickert N; Grady C
N Engl J Med; 1999 Jul; 341(3):198-203. PubMed ID: 10403861
[No Abstract] [Full Text] [Related]
4. A world of research subjects.
Emanuel EJ
Hastings Cent Rep; 1998; 28(6):25. PubMed ID: 9868607
[No Abstract] [Full Text] [Related]
5. Research versus innovation: real differences.
Morreim H
Am J Bioeth; 2005; 5(1):42-3; author reply W15-8. PubMed ID: 16036658
[No Abstract] [Full Text] [Related]
6. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
7. The clinical-trials bottleneck.
Russo F
Atl Mon; 1999 May; 283(5):30, 32, 34, 36. PubMed ID: 11657639
[No Abstract] [Full Text] [Related]
8. Clinical trials: patient issues in the decision-making process.
Bujorian GA
Oncol Nurs Forum; 1988; 15(6):779-83. PubMed ID: 3205836
[No Abstract] [Full Text] [Related]
9. Innocents abroad? The ethics of international research.
Kahn J; Mastroianni A
Minn Med; 1999 Jul; 82(7):28-9. PubMed ID: 10431542
[No Abstract] [Full Text] [Related]
10. The duty to exclude: excluding people at undue risk from research.
Weijer C; Fuks A
Clin Invest Med; 1994 Apr; 17(2):115-22. PubMed ID: 8004847
[TBL] [Abstract][Full Text] [Related]
11. Justice and research design: the case for a semi-randomization clinical trial.
Veatch RM
Clin Res; 1983 Feb; 31(1):12-22. PubMed ID: 10299203
[No Abstract] [Full Text] [Related]
12. Nonvalidated therapies and HIV disease. McGill/Boston Research Group.
Freedman B
Hastings Cent Rep; 1989; 19(3):14-20. PubMed ID: 2656580
[TBL] [Abstract][Full Text] [Related]
13. A response to a purported ethical difficulty with randomized clinical trials involving cancer patients.
Freedman B
J Clin Ethics; 1992; 3(3):231-4. PubMed ID: 1392047
[No Abstract] [Full Text] [Related]
14. Noncompliance in AIDS research.
Arras JD
Hastings Cent Rep; 1990; 20(5):24-32. PubMed ID: 2228583
[TBL] [Abstract][Full Text] [Related]
15. Trust, The fragile foundation of contemporary biomedical research.
Kass NE; Sugarman J; Faden R; Schoch-Spana M
Hastings Cent Rep; 1996; 26(5):25-9. PubMed ID: 8891706
[TBL] [Abstract][Full Text] [Related]
16. Selling experiment treatment.
Oldham RK
Hastings Cent Rep; 1990; 20(6):43-4. PubMed ID: 2283290
[No Abstract] [Full Text] [Related]
17. Regulating research on the terminally ill: a proposal for heightened safeguards.
Addicott DC
J Contemp Health Law Policy; 1999; 15(2):479-524. PubMed ID: 10394764
[No Abstract] [Full Text] [Related]
18. The Declaration of Helsinki, CIOMS and the ethics of research on vulnerable populations.
Zion D; Gillam L; Loff B
Nat Med; 2000 Jun; 6(6):615-7. PubMed ID: 10835665
[No Abstract] [Full Text] [Related]
19. Can patients be asked to pay for experimental treatment?
Lind SE
Clin Res; 1984 Oct; 32(4):393-8. PubMed ID: 6509865
[No Abstract] [Full Text] [Related]
20. Protectionism and the new research imperative in pediatric AIDS.
Ackerman TF
IRB; 1990; 12(5):1-5. PubMed ID: 11654001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
